Dermisonics Inc. (DMSI.OB) is a Pennsylvania based company focused on developing new and innovative drug delivery technologies. In Particular, the Company is engaged in alternative drug delivery systems for small and large molecule drugs.
Advanced trasdermal drug delivery technologies create a non-invasive delivery method of macromolecular pharmaceutical formulations. The Company’s proprietary technology makes it possible to transfer drugs through the skin by applying a low-level ultrasonic wave.
Dermisonics’ business strategy includes partnering with pharmaceutical and healthcare companies that can provide financial support and assist in commercializing their products. Currently, the Company is focusing on existing FDA approved products for the reason that it reduces clinical risks and does not require costly and time consuming pre-clinical and clinical studies.
Let us hear your thoughts: Dermisonics Inc. Message Board